Covid 19 Research using Clinical Trials (Home Page)
New QIAstat-Dx fully automatic multiple PCR detection platformWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
Correlated MeSH Terms (1)
|
Name (Synonyms) |
Correlation |
D018352 | Coronavirus Infections NIH | 0.04 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
Our project intends to independently develop a fully enclosed rapid detection system for a
total of 22 pathogens, including SARS-CoV-2, on the basis of the QIAstat-Dx fully automatic
multiple PCR detection platform. The reasonably designed experiments are used to verify the
performance of the cartridge detection and prove its clinical application value. The 22
pathogens tested in this project includes 4 coronavirus subtypes, A / B flu, parainfluenza
virus, respiratory syncytial virus, etc., which is of great significance for the differential
diagnosis of similar patients.
NCT04311398 COVID-19 Diagnostic Test: New QIAstat-Dx fully automatic multiple PCR detection platform
Primary Outcomes
Measure: Sensitivity, spectivity turnaround time of the New QIAstat-Dx fully automatic multiple PCR detection platform Time: 3 months
No related HPO nodes (Using clinical trials)